Stadol vs. Valproate sodium: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Stadol and Valproate sodium. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 45,743 people who take Stadol and Valproate sodium, and is updated regularly.
What is Stadol?
Stadol has active ingredients of butorphanol tartrate. It is often used in migraine. eHealthMe is studying from 5,546 Stadol users. Check the latest studies of Stadol.
What is Valproate sodium?
Valproate sodium has active ingredients of valproate sodium. It is often used in epilepsy. eHealthMe is studying from 24,044 Valproate sodium users. Check the latest studies of Valproate sodium.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
45,743 people who take Stadol and Valproate sodium are studied.
Drugs being compared in this study:
- Valproate Sodium (valproate sodium)
- Stadol (butorphanol tartrate)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Stadol:
- not at all: 2.56 %
- somewhat: 28.21 %
- moderate: 33.33 %
- high: 23.08 %
- very high: 12.82 %
Valproate Sodium:
- not at all: 3.83 %
- somewhat: 11.96 %
- moderate: 28.71 %
- high: 39.71 %
- very high: 15.79 %
Want to compare Stadol with Valproate sodium?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Ayano G, "Bipolar Disorders and Valproate: Pharmacokinetics, Pharmacodynamics and Therapeutic Effects and Indications of Valproate: Review of Articles", Bipolar Disord, 2017 Jan .
- Bansal S, Gupta SK, "Sodium Valproate induced priapism in an adult with bipolar affective disorder", Indian journal of pharmacology, 2013 Jan .
- Ayano G, "Bipolar Disorders and Valproate: Pharmacokinetics, Pharmacodynamics and Therapeutic Effects and Indications of Valproate: Review of Articles", Bipolar Disord, 2017 Jan .
- Bansal S, Gupta SK, "Sodium Valproate induced priapism in an adult with bipolar affective disorder", Indian journal of pharmacology, 2013 Jan .
Related studies
Alternative drugs to, pros and cons of:
- Stadol (5,498 reports)
- Valproate sodium (23,476 reports)
Browse all side effects of Stadol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Valproate sodium:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on butorphanol tartrate and valproate sodium (the active ingredients of Stadol and Valproate sodium, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Exjade cause Uveitis? - 23 seconds ago
- Atripla and Renal Failure Acute for Women aged 50-59 - 32 seconds ago
- Atripla and Renal Failure for Women aged 50-59 - 33 seconds ago
- Atripla and Kidney Failure for Women aged 50-59 - 33 seconds ago
- Atripla and Arf for Women aged 50-59 - 33 seconds ago
- Atripla and Acute Kidney Failure for Women aged 50-59 - 34 seconds ago
- Diverticulum Intestinal Haemorrhagic and drugs of ingredients of ondansetron hydrochloride - 38 seconds ago
- Could Remicade cause Sensation Of Heaviness? - 44 seconds ago
- Could Moviprep cause Gallstones? - 50 seconds ago
- Could Detrol cause Oesophageal Reflux? - 52 seconds ago